UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Formulation of novel dry powder inhalation for fluticasone propionate and salmeterol xinafoate with capsule-based device

Pharmaceutical development and technology, 2018-02, Vol.23 (2), p.158-166

2018

Volltextzugriff (PDF)

Enhanced oral bioavailability of salmeterol by loaded PLGA microspheres: preparation, in vitro, and in vivo evaluation

Drug delivery, 2016-01, Vol.23 (1), p.248-253

2016

Volltextzugriff (PDF)

Budesonide/salmeterol in fixed-dose combination for the treatment of asthma

Expert review of respiratory medicine, 2016-02, Vol.10 (2), p.113-125

2016

Volltextzugriff (PDF)

The assessment of effectiveness, tolerance, and patient satisfaction with the use of a new fixed-dose combination product, containing salmeterol and fluticasone propionate, Salflumix Easyhaler® in the treatment of asthma in the daily clinical practice

The Journal of asthma, 2023-04, Vol.60 (4), p.754-760

2023

Volltextzugriff (PDF)

Synthesis and characterization of double molecular imprinted nanoparticles and investigation to adsorption of respiratory drugs

Polymer-plastics technology and engineering, 2022-03, Vol.61 (4), p.384-399

2022

Volltextzugriff (PDF)

Comparison of fractional exhaled nitric oxide in asthmatics with and without allergic rhinitis

Biomarkers, 2021-02, Vol.26 (2), p.174-183

2021

Volltextzugriff (PDF)

Evaluation of fluticasone propionate/salmeterol for the treatment of COPD: a systematic review

Expert review of respiratory medicine, 2020-06, Vol.14 (6), p.621-635

2020

Volltextzugriff (PDF)

Effect of Fluticasone Propionate/Salmeterol (250/50) on COPD Exacerbations and Impact on Patient Outcomes

Chronic obstructive pulmonary disease, 2009, Vol.6 (5), p.320-329

2009

Volltextzugriff (PDF)

Effects of regular treatment with combination of salmeterol/fluticasone propionate and salmeterol alone in cough variant asthma

The Journal of asthma, 2015-06, Vol.52 (5), p.512-518

2015

Volltextzugriff (PDF)

Improved Ability to Perform Strenuous Activities After Treatment with Fluticasone Propionate Salmeterol Combination in Patients with Persistent Asthma

The Journal of asthma, 2003, Vol.40 (7), p.815-822

2003

Volltextzugriff (PDF)

An evaluation of asthma medication utilization for risk evaluation and mitigation strategies (REMS) in the United States: 2005-2011

The Journal of asthma, 2013-09, Vol.50 (7), p.776-782

2013

Volltextzugriff (PDF)

Impact of the Arg 16 allele of the B2AR gene on the effect of withdrawal of LABA in patients with moderate to severe asthma

The Journal of asthma, 2016-10, Vol.53 (8), p.783-789

2016

Volltextzugriff (PDF)

Recent advances in COPD disease management with fixed-dose long-acting combination therapies

Expert review of respiratory medicine, 2014-06, Vol.8 (3), p.357-379

2014

Volltextzugriff (PDF)

Montelukast as an Add-On Therapy to Inhaled Corticosteroids in the Treatment of Severe Asthma in Elderly Patients

The Journal of asthma, 2012-06, Vol.49 (5), p.530-534

2012

Volltextzugriff (PDF)

Association between adherence with fixed dose combination fluticasone propionate/salmeterol on asthma outcomes and costs

Current medical research and opinion, 2008-12, Vol.24 (12), p.3435-3442

2008

Volltextzugriff (PDF)

Adherence to controller therapy for chronic obstructive pulmonary disease: a review

Current medical research and opinion, 2010-10, Vol.26 (10), p.2421-2429

2010

Volltextzugriff (PDF)

Addition of a 5-lipoxygenase-activating protein inhibitor to an inhaled corticosteroid (ICS) or an ICS/long-acting beta-2-agonist combination in subjects with asthma

Current medical research and opinion, 2013-12, Vol.29 (12), p.1663-1674

2013

Volltextzugriff (PDF)

Perception of Bronchoconstriction: A Complementary Disease Marker in Children with Asthma

The Journal of asthma, 2013-08, Vol.50 (6), p.560-564

2013

Volltextzugriff (PDF)

Accuracy of Death Certificates in COPD: Analysis from the TORCH Trial

Chronic obstructive pulmonary disease, 2010-06, Vol.7 (3), p.179-185

2010

Volltextzugriff (PDF)

The Improvement of Cognitive Functions in Patients with Bronchial Asthma after Therapy

The Journal of asthma, 2010-12, Vol.47 (10), p.1148-1152

2010

Volltextzugriff (PDF)

Asthma exacerbations in African Americans treated for 1 year with combination fluticasone propionate and salmeterol or fluticasone propionate alone

Current medical research and opinion, 2008-06, Vol.24 (6), p.1669-1682

2008

Volltextzugriff (PDF)

Deterioration in Asthma Control When Subjects Receiving Fluticasone Propionate/Salmeterol 100/50 mcg Diskus are "Stepped-Down"

The Journal of asthma, 2008-01, Vol.45 (8), p.681-687

2008

Volltextzugriff (PDF)

Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma

Current medical research and opinion, 2004-01, Vol.20 (2), p.225-240

2004

Volltextzugriff (PDF)

A new methodology for predicting human pharmacokinetics for inhaled drugs from oratracheal pharmacokinetic data in rats

Xenobiotica, 2012-01, Vol.42 (1), p.75-85

2012

Volltextzugriff (PDF)

Evaluation of salmeterol xinafoate plus fluticasone propionate for the treatment of chronic obstructive pulmonary disease

Expert opinion on pharmacotherapy, 2013-10, Vol.14 (14), p.1993-2002

2013

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Aktive Filter

KollektionTaylor & Francis

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(75)

Sprache

Englisch
(75)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Salmeterol Xinafoate
(71)
Humans
(66)
Albuterol - Analogs & Derivatives
(63)
Science & Technology
(60)
Life Sciences & Biomedicine
(59)
Male
(47)
Asthma - Drug Therapy
(46)
Female
(44)
Albuterol - Administration & Dosage
(40)
Adult
(33)
Fluticasone
(32)
Asthma
(31)
Middle Aged
(31)
Respiratory System
(31)
Administration, Inhalation
(29)
Salmeterol
(29)
Albuterol - Therapeutic Use
(28)
Bronchodilator Agents - Administration & Dosage
(27)
Androstadienes - Administration & Dosage
(26)
Aged
(24)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Formulation of novel dry powder inhalation for fluticasone propionate and salmeterol xinafoate with capsule-based device

Enhanced oral bioavailability of salmeterol by loaded PLGA microspheres: preparation, in vitro, and in vivo evaluation

Budesonide/salmeterol in fixed-dose combination for the treatment of asthma

The assessment of effectiveness, tolerance, and patient satisfaction with the use of a new fixed-dose combination product, containing salmeterol and fluticasone propionate, Salflumix Easyhaler® in the treatment of asthma in the daily clinical practice

Synthesis and characterization of double molecular imprinted nanoparticles and investigation to adsorption of respiratory drugs

Comparison of fractional exhaled nitric oxide in asthmatics with and without allergic rhinitis

Evaluation of fluticasone propionate/salmeterol for the treatment of COPD: a systematic review

Effect of Fluticasone Propionate/Salmeterol (250/50) on COPD Exacerbations and Impact on Patient Outcomes

Effects of regular treatment with combination of salmeterol/fluticasone propionate and salmeterol alone in cough variant asthma

Improved Ability to Perform Strenuous Activities After Treatment with Fluticasone Propionate Salmeterol Combination in Patients with Persistent Asthma

An evaluation of asthma medication utilization for risk evaluation and mitigation strategies (REMS) in the United States: 2005-2011

Impact of the Arg 16 allele of the B2AR gene on the effect of withdrawal of LABA in patients with moderate to severe asthma

Recent advances in COPD disease management with fixed-dose long-acting combination therapies

Montelukast as an Add-On Therapy to Inhaled Corticosteroids in the Treatment of Severe Asthma in Elderly Patients

Association between adherence with fixed dose combination fluticasone propionate/salmeterol on asthma outcomes and costs

Adherence to controller therapy for chronic obstructive pulmonary disease: a review

Addition of a 5-lipoxygenase-activating protein inhibitor to an inhaled corticosteroid (ICS) or an ICS/long-acting beta-2-agonist combination in subjects with asthma

Perception of Bronchoconstriction: A Complementary Disease Marker in Children with Asthma

Accuracy of Death Certificates in COPD: Analysis from the TORCH Trial

The Improvement of Cognitive Functions in Patients with Bronchial Asthma after Therapy

Asthma exacerbations in African Americans treated for 1 year with combination fluticasone propionate and salmeterol or fluticasone propionate alone

Deterioration in Asthma Control When Subjects Receiving Fluticasone Propionate/Salmeterol 100/50 mcg Diskus are "Stepped-Down"

Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma

A new methodology for predicting human pharmacokinetics for inhaled drugs from oratracheal pharmacokinetic data in rats

Evaluation of salmeterol xinafoate plus fluticasone propionate for the treatment of chronic obstructive pulmonary disease

Aktive Filter

Suchergebnisse filtern